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Abstract 
Background: Functional Neurological Symptoms (FNS) refer to symptoms that resemble 
those of neurological conditions (e.g. seizures, limb paralysis/weakness, dizziness) but have 
no associated organic cause. Cognitive behaviour therapy (CBT) may be an effective 
intervention for individuals with FNS. This study systematically reviews the evidence 
regarding the effectiveness of this intervention and examines the methodological quality of 
the research in this area. 
Method: Four databases were searched electronically, yielding six papers that met inclusion 
and exclusion criteria. The reference lists of these included papers were then hand 
searched for further relevant articles resulting in the addition of two further relevant 
papers. The methodological quality of these eight papers was assessed using the Clinical 
Trials Assessment Measure [1] and effect sizes were calculated. 
Results: Two studies employed Randomised Controlled Trial (RCT) methodology; the 
remaining studies were pre-post trials. Only one of the included studies reached the cut-off 
for adequate methodological quality suggested by Wykes and colleagues [2]. All studies 
except for one found significant benefits of CBT for FNS and effect sizes were medium to 
large.  
Conclusion: There is preliminary evidence suggesting that CBT may be a useful intervention 
for FNS. RCTs are difficult to conduct with this population and future research should 
attempt to utilise other suitable research designs, for example Single Case Experimental 
Designs (SCEDs). Further studies of high methodological quality are needed. 
 
Keywords: Functional Neurological Symptoms, Conversion Disorder, Cognitive Behaviour 
Therapy, Systematic Review 
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Introduction 
Functional neurological symptoms (FNS) refer to symptoms that resemble those of 
neurological conditions but have no associated organic cause. Examples include limb 
weakness, movement disorders, seizures and blackouts. FNS have been known by many 
different labels including medically unexplained symptoms, conversion disorder, 
dissociative disorder and psychosomatic disorder. For the purposes of this review we will 
refer to these disorders as ‘functional’ as research has shown that this label is the most 
acceptable to patients [3]. DSM-5 refers to these conditions as ‘conversion disorders’ and 
defines them as ‘one or more symptoms or deficits affecting voluntary motor or sensory 
function that suggest a neurological or other general medical condition’ [4]. They further 
specify that psychological factors play a role in the onset or maintenance of these 
symptoms.  
 The Scottish Neurological Symptoms Study [5], a multi-centre prospective cohort 
study of 3781 first attendance neurology outpatients found that 30% had symptoms that 
were either ‘not at all’ or only ‘somewhat’ explained by neurological disease indicating that 
FNS are a prevalent problem. The study also found that these patients had similar levels of 
physical impairment to those whose symptoms had an organic cause but that they tended 
to have higher rates of distress. Twenty seven percent of FNS patients in the study were not 
in employment due to health reasons, compared with nineteen percent of those with 
organic symptoms. These figures suggest that FNS have a high economic impact as well as 
causing significant disability to individuals.  
It has been widely suggested that psychological factors may play a significant role in 
the development and maintenance of FNS. It has been found that the number of 
psychological symptoms reported by individuals with functional somatic symptoms may 
correlate with the number of functional symptoms reported [6]. Patients with FNS have 
been shown to display higher rates of emotional distress when compared to those with 
neurological disease [5]. There is also evidence that aversive experiences in childhood are 
more common in these patients [7]. Functional neurological symptoms may be maintained 
by a combination of cognitive, behavioural, emotional and physiological factors, for 
example catastrophic cognitive interpretations of bodily events, avoidance/safety 
behaviours and mood [8]. Cognitive Behavioural Therapy (CBT) has been shown to be an 
effective treatment for other somatoform disorders [9 - 12]. It follows that psychological 
treatments such as CBT may be effective in treating these disorders.  
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 A number of review articles of CBT for conversion disorders have been published to 
date. Allen and Woodfolk conducted a review of the literature on CBT for somatoform 
disorders, including conversion disorder/functional neurological symptoms [13]. This 
review did not identify any controlled trials of CBT for this population.  Hopp & LaFrance 
conducted a review of CBT specifically for FNS [14]. The study reviewed a number of articles 
relating to CBT for non-epileptic seizures (NES). One case report of CBT for functional 
movement disorder was also reviewed but no articles were found relating to CBT for other 
FNS. This review did not assess the methodological quality of included studies. The authors 
concluded that further controlled treatment trials were needed to determine efficacy. To 
our knowledge there has not been an attempt to date to systematically review and 
evaluate the methodological quality of the literature relating to CBT for the treatment of 
functional neurological disorders.  
 
Aims 
This systematic review aims to investigate the efficacy of CBT for FNS and to formally 
evaluate the methodological quality of the literature in this area.  
 
Methods 
Search Procedures 
An electronic search of Medline, Embase, Web of Science and PsycINFO databases was 
conducted on 17/05/14.  
 The following search terms were utilised: 
Cognitive behav* OR CBT OR psychological intervention* OR psychological therap*  
AND 
Mesh term (conversion disorder), Keywords (conversion disorder* OR conversion 
symptom* OR medically unexplained symptom* OR functional disorder* OR functional 
symptom* OR functional neurolog* disorder* OR functional neurolog* symptom* OR 
somat* disorder* OR somat* symptom* OR psychosomat* disorder* OR psychosomat* 
symptom* OR dissociat* disorder* OR dissociat* symptom* OR psychogenic disorder* OR 
psychogenic symptom* OR non-organic disorder* OR non-organic symptom*) 
 (* denotes truncation command to identify all possible endings of the word). 
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Selection Criteria 
Inclusion Criteria 
 Randomised controlled studies, pre-post studies, single case experimental design 
studies. 
 Adult male or female, 18 years of age or older with any type of functional (non-
organic) neurological disorder. 
 Studies investigating the efficacy of an individual or group intervention of CBT for 
this population. 
 Studies published in English 
 
Exclusion Criteria 
 Single case studies 
 Books/book chapters 
 Review Studies 
 Commentaries 
 
Sample Description 
The results of the search process are illustrated in Figure 1 below. A search of Medline, 
Embase, PsycINFO and Web of Science databases yielded 655 references. Search results 
from each database were transferred to Refworks referencing software. Following the 
removal of duplicates 461 studies remained. The titles of the remaining studies were 
screened resulting in a further 297 irrelevant papers being removed. The abstracts of the 
remaining 164 articles were reviewed and studies that clearly did not meet the 
inclusion/exclusion criteria were removed.  The full texts of the remaining 23 articles were 
reviewed leaving 6 articles that met the criteria [15 - 20]. Two of these articles [19, 20] 
reported on different follow-up periods of the same study. The reference lists of these 6 
remaining papers were hand searched leading to the inclusion of a further two studies [21, 
22]. The final review included eight articles relating to seven studies.  
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Figure 1 Flow Diagram Illustrating Search Process  
 
Quality Rating 
The methodological rigour of each study was evaluated using the Clinical Trials Assessment 
Measure (CTAM) [1]. This is an assessment tool designed for assessing the quality of trials 
of psychological treatments in mental health. It consists of fifteen items grouped into six 
areas: sample (10 points); allocation to treatment (16 points); outcome assessment (32 
points); control groups (16 points); analysis (15 points); and description/quality of 
treatments (11 points). The measure has a maximum possible score of one hundred (see 
Appendix 1.2). The scale has adequate internal consistency, excellent concurrent validity 
and good blind inter-rater agreement [2]. The CTAM was selected for use in this review due 
to its good psychometric properties, brevity and ease of use and the fact that it has been 
specifically designed for assessing trials of psychological treatments such as CBT. 
 Two reviewers rated all included studies in order to assess inter-rater reliability. 
Agreement between the reviewers was high (91%) and any discrepancies were resolved 
11 
 
through discussion. Scores on the CTAM varied, with a mean of 38.00 (SD = 20.60) and a 
median of 31 (range = 10–68). Wykes and colleagues suggested that a total CTAM score of 
65 or higher would indicate adequate methodological quality, however the validity of this 
cut-off is yet to be investigated [2]. 
 
Results 
Each article is summarised in terms of the type of functional disorder examined, the design 
of the study, the number and characteristics of subjects and control subjects, interventions, 
outcomes evaluated and quality (see Table 1).  
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Table 1  Description and Quality Rating of Included Studies 
Study CTAM 
Rating 
Design Subjects Controls Intervention Outcome 
Measures 
Conclusions Effect Sizes 
Non-epileptic seizures 
       
Goldstein et al., 
[21] 
26 Non-controlled 
pre-post study. 
6 month follow-
up 
N = 20, 16 
received 
treatment M=2, 
F=14average age 
34.9±13.4 
n/a 12 individual CBT 
sessions (14 hours 
total duration). 
Weekly/Fortnightly 
Primary: 
Seizure frequency 
FQ 
WSAS 
HADS 
Employment Status 
Secondary Measures: 
MHLC 
IPQ 
 
Intention to treat 
analysis: 
Post-treatment: 
significant reduction in 
seizure frequency 
6-month follow-up: 
25% seizure free 
Seizure frequency 
Pre vs. Post 
treatment  
(r = -.61) 
Post-treatment vs. 
6-month follow-up  
(r = -.11) 
 
Goldstein et al., 
[17] 
68 RCT, 6 month 
follow-up 
N = 33, M=9, F=24 
Age 37.4 ± 12.6 
N = 31, 
M=7, 
F=26 
Age 35.9 
± 15.1 
CBT (12 one hour 
sessions) and 
standard medical 
care vs. Standard 
medical care only 
Monthly seizure 
frequency 
Seizure freedom 
WSAS 
HADS 
Modified CSRI 
 
CBT group significantly 
lower seizure 
frequency at 
treatment end. 
 
Trend towards lower 
seizure frequency in 
CBT group at follow-
up. 
 
Seizure frequency 
Intervention vs. 
Control at end of 
treatment  
(d = .75) 
Intervention vs. 
Control at 6-month 
follow-up 
(d = .42) 
 
LaFrance et al., 
[15] 
25 Non-controlled 
pre-post study. 
12 month 
follow-up 
N = 21, 20 
analysed, M=4, 
F=17, average age 
36.0 
n/a CBT (12 one hour 
sessions) 
Patient recorded 
seizure diary 
BDI 
MHRSD 
DTS 
DES 
BIS 
FAD 
SCL-90 
GAF 
OHS 
LIFE-RIFT 
WoC 
QOLIE 
 
Significant reduction in 
weekly seizure 
frequency post 
treatment 
Seizure frequency 
pre vs. post 
treatment  
(r = .66) 
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Study CTAM 
Rating 
Design Subjects Controls Intervention Outcome 
Measures 
Conclusions Effect Sizes 
Non-epileptic seizures continued…       
 
Kuyk et al., [22] 
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Non-controlled 
pre-post study 
with 6 month 
follow up 
 
N=29, 26 received 
treatment, 4 
patients with a 
co-morbid 
diagnosis of 
epilepsy were 
excluded from 
analysis, follow-
up n=16 
 
 
 
n/a 
 
Inpatient 
multidisciplinary 
treatment based 
on CBT principles 
 
Seizure frequency  
SCL-90 
BDI 
STAI 
UCL 
SF-36 
DISQ 
 
Significant reduction in 
seizure frequency post 
treatment and a 
further significant 
reduction from end of 
treatment to follow-up 
 
Seizure frequency 
Pre vs. Post 
treatment  
(r = -.35) 
Post-treatment vs. 
6-month follow-up  
(r = -.35) 
 
Conwill et al., 
[16] 
31 Pre-post group 
study 
N = 16 (NES=10, 
other FNS=6), 
M=4, F=12, 
average age 
37.4±11.9 
n/a CBT-based group 
therapy. NES - 4 
sessions, other 
FNSs – 5 sessions 
both 1 hour 
duration, weekly 
Monthly attack 
frequency 
SF-36 
HADS 
CGI 
Neuropsychiatric 
assessment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outcomes NES 
patients only: no 
significant differences 
on any outcome 
measures 
 No significant 
differences found 
post intervention 
therefore no effect 
sizes were 
calculated 
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Study CTAM 
Rating 
Design Subjects Controls Intervention Outcome 
Measures 
Conclusions Effect Sizes 
Functional Dizziness 
       
Edelman et al., 
[19] 
& 
Mahoney et al., 
[20] – follow-up 
paper 
58 RCT 
1 and 6 month 
follow-up 
N = 20 
M=11, F=30, 
average age 
46.78±12.65 
 
Follow-up paper: 
N = 23 
M=12, F=32, 
average age 
46.7±12.97 
N = 21, 
wait-list 
3 individual CBT 
sessions, wait-list 
received 
intervention 4 
weeks later 
MINI 
DHI 
DSI 
SBI 
DASS-21 
Significant reductions 
on the DHI, DSI & SBI 
but no significant 
change on DASS-21 at 
post treatment  
Improvements made 
post-treatment were 
maintained at 6-month 
follow-up 
Treatment Group: 
DHI (d = 1.38) 
DSI (d = 1.17) 
SBI (d = 1.58) 
Waitlist Group (post 
treatment): 
DHI (d = 1.02) 
DSI (d = 0.98) 
SBI (d = 1.34) 
 
Baseline vs. 6-mth 
follow-up: 
Treatment Group 
DHI (d = 1.36) 
DSI (d = 1.18) 
SBI (d = 1.51) 
Waitlist Group  
DHI (d = 1.01) 
DSI (d = 0.88) 
SBI (d = 1.39) 
Functional Dysphonia        
Daniilidou et 
al., [18] 
48 Pre-post 
consecutive 
cohort 
controlled 
study. Voice 
therapy vs. CBT 
enhanced voice 
therapy. 
Multiple t-tests 
N = 16, outcome 
data for 13 
N = 16, 
outcome 
data for 
15 
6 individual one 
hour weekly 
sessions of voice 
therapy/CBT 
enhanced voice 
therapy. 
GRBAS 
VPQ 
VoiSS 
HADS 
GHQ-28 
Control group 
improved significantly 
on VPQ, VoiSS & GHQ-
28 
CBT group improved 
significantly on all 
measures and 
improved significantly 
more than controls on 
GHQ-28 
Control group: VPQ 
(d = -1.5)* 
VoiSS (d = -.9)* 
GHQ-28 (d = -.6)* 
CBT Group: 
GRBAS (d = -1.4)* 
VPQ (d = -1.8)* 
VoiSS (d = -1.4)* 
HADS anx (d = -.4)* 
HADS dep (d =  -.6)* 
GHQ-28 (d = -.9)* 
Bold typeface indicates effect sizes were calculated by the first author of this review 
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Abbreviations: 
 
BDI    - Beck depression inventory [23] 
BIS    - Barrett Impulsivity Scale [24] 
CGI    - The Clinical Global Impression Scale [25] 
CSRI    - Client Service Receipt Inventory [26] 
CTAM   - Clinical Trials Assessment Measure [1] 
DASS-21   - Depression, Anxiety and Stress Scales 21 [27] 
DES    - Dissociative Experiences Scale [28] 
DHI    - Dizziness Handicap Inventory [29] 
DISQ    - Dissociation Questionnaire [30] 
DSI    - Dizziness Symptom Inventory [31] 
DTS    - Davidson Trauma Scale [32] 
FAD    - Family Assessment Device [33] 
FQ    - Fear Questionnaire [34] 
GAF    - Global Assessment of Functioning [35] 
GHQ-28   - General health Questionnaire 28 [36] 
GRBAS   - Grade, Roughness, Breathiness, Asthenia, Strain Scale [37] 
HADS   - Hospital Anxiety and Depression Scale [38] 
IPQ    - Illness Perception Questionnaire [39] 
LIFE-RIFT   - Longitudinal Interval Follow-UP Evaluation Range of Impaired Functioning [40] 
MHLC   - Multidimensional Health Locus of Control Scale [41] 
MHRSD   - The Modified Hamilton Rating Scale for Depression [42] 
MINI    - Mini International Neuropsychiatric Interview [43] 
OHS    - Oxford handicapped Scale [44] 
SBI    - Safety Behaviour Inventory [45] 
SCL-90   - Symptom Checklist-90 [46] 
SF-36   - 36-item Short Form Health Survey [47]  
STAI    - State-Trait Anxiety Inventory [48] 
UCL    - Utrecht Coping List [49] 
QOLIE   - Quality of life in epilepsy [50] 
VoiSS   - Voice Symptoms Scale [51] 
VPQ    - Voice Performance Questionnaire [52] 
WoC    - Ways of Coping [53] 
WSAS   - Work and Social Adjustment Scale [54] 
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Data Synthesis 
Due to the heterogeneity of included studies in relation to disorders treated, characteristics 
of the interventions, outcomes measured and methods of analysis utilised, meta-analysis of 
the results was considered to be inappropriate. Narrative synthesis of the included studies 
was therefore completed. 
 
Non-Epileptic Seizures 
The term non-epileptic seizures (NES) is used to refer to events which greatly resemble 
epileptic seizures in appearance but are not accompanied by changes in electrical activity in 
the brain which characterise epilepsy. They are among the most common type of FNS [55]. 
Antiepileptic medications are not an effective treatment for these individuals; therefore the 
focus for treatment has turned to psychological interventions with a small number of trials 
of CBT for NES being carried out in recent years. 
 Goldstein and colleagues [21] employed a non-randomised, pre-post design to 
evaluate the effect of CBT (12 sessions delivered by a CBT trained nurse therapist following 
a detailed treatment protocol) on seizure frequency and psychosocial functioning both at 
end of treatment and at six month follow up. Monthly seizure frequency and anxiety and 
depression (measured using the HADS) were significantly reduced post-treatment and 
these gains were maintained at six month follow up. The intervention was well described 
and employed a manual however there was no assessment of protocol adherence or 
treatment quality. The analysis employed was appropriate and included all randomised 
participants. The dropout rate was 20% and comparisons were performed between 
completers and non completers indicating no significant differences. 
 The study received a CTAM rating of 26 out of 100 indicating that methodological 
rigour was below the level considered to be adequate by Wykes and colleagues [2]. The 
study did not employ a control group. Assessments were not carried out by independent 
assessors blinded to treatment condition; therefore this may have biased the results. The 
study had a small sample size (n=16) and did not report a power calculation. However the 
researchers found a significant difference in seizure frequency post-treatment compared to 
baseline with a large effect. 
 Kuyk and colleagues [22] evaluated a non-randomised uncontrolled study of a 
multidisciplinary inpatient treatment based on cognitive behavioural principles with six 
month follow up. The authors report a significant decrease in seizure frequency at end of 
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treatment and follow up, however the study suffered a number of methodological issues. 
The sample size was relatively small (n=29), including three drop outs and four exclusions 
due to a co-morbid diagnosis of epilepsy. A further six individuals were lost to follow up. 
There was no investigation of dropouts and they were not included on the analysis. The 
description of the intervention was insufficient and this was not manualised. Finally 
assessments were not carried out by independent assessors. The CTAM score for this study 
was 10 out of 100 suggesting poor methodological rigour. The study reports significant 
reductions in seizure frequency post-treatment and at six month follow-up and effect sizes 
at both time points were of medium strength. 
 LaFrance and colleagues [15] again evaluated the effectiveness of CBT (12 weekly 
sessions) for reducing NES frequency through a non-randomised pre-post study. Seizures 
reduced significantly at end of treatment and significant improvements were found in 
quality of life, family functioning and psychosocial functioning. Sessions were administered 
according to a protocol by an experienced CBT practitioner and the quality of the 
intervention and adherence to the protocol were monitored through audio recordings. One 
of the inclusion criteria of the study required the diagnosis of NES to have been established 
through video EEG monitoring which resulted in 79% of screened participants being 
excluded. This may limit the generalisability of the results to clinical practice. The sample 
size was small (n=21) with a 19% attrition rate (n=17) and was not based on a power 
calculation. Drop outs were investigated and all but one of the original twenty one 
participants were included in a partial intention to treat analysis (one was excluded as they 
only completed baseline measures). Assessments were not carried out by independent 
assessors and this may have introduced bias. The study received a CTAM score of 25 out of 
100 which is below the cut-off suggested by Wykes and colleagues [2] for adequate 
methodological quality. Effect sizes however, were large. 
 Conwill and colleagues [16] conducted the first efficacy study of a CBT-based group 
therapy for NES (n=10) and other FNS (6). When looking at the results for NES patients 
individually the study failed to find any significant benefit of CBT for seizure reduction. The 
CTAM rating for the study was 31 out of 100 suggesting that the methodological rigour was 
below an adequate level. The study was uncontrolled and there was no randomisation. 
Standardised measures were used to evaluate the intervention and the treatment was 
adequately described with adherence monitored, although it was not clear whether a 
treatment protocol was followed.Goldstein and colleagues [17] conducted the only 
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randomised controlled trial (RCT) on this population to date, comparing CBT against 
standard medical care (SMC) with six month follow up data. Seizure frequency was 
significantly reduced in the CBT group versus the SMC group at the end of treatment and 
there was a trend towards the superiority of the CBT intervention at six month follow up. 
No significant differences were found between the groups on depression or anxiety as 
measured by the HADS [38]. This was a well designed study with a reasonable sample size 
(SMC=31, CBT=33). Randomisation was carried out independent of the research team, 
analysis of results was appropriate and intention to treat analysis was performed. The 
treatment was described in detail and followed a protocol and CBT quality and therapeutic 
alliance was assessed. This study was the only included study rated as having adequate 
methodological quality as defined by Wykes and colleagues [2]. Effect sizes for the CBT 
intervention showed a medium to large effect post treatment and a medium effect at six 
month follow up.  
 
Functional Voice Disorders 
Functional voice disorder refers to a difficulty in speaking which usually manifests itself 
through hoarseness in the absence of a physical cause. Research in the area has shown that 
this group of individuals tend to have poorer psychological functioning than those with an 
organic cause. Willinger and colleagues [56] found that patients with functional dysphonia 
had significantly higher scores than controls on self-reported symptoms of depression, 
anxiety and health anxiety and suggested that these symptoms should be addressed when 
working with these patients. Baker [57] investigated the psychological factors that 
contribute to the development of functional voice disorders and identified that these 
individuals tend to have higher levels of anxiety, depression and have problems 
processing/expressing negative emotions. Butcher and colleagues [58-61] have strongly 
advocated the use of CBT integrated with traditional voice therapy by Speech and Language 
Therapists in the management of functional voice disorders in order to improve both voice 
quality and psychological wellbeing. Despite this, few treatment studies utilising CBT for 
this population have been undertaken. 
 Only one published pilot study was identified that compared conventional voice 
therapy with ‘CBT-enhanced' voice therapy in a nonrandomised consecutive cohort design 
[18]. The authors compared participants receiving conventional voice therapy to those 
receiving conventional voice therapy with the addition of CBT. Both groups showed 
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significant improvements on the GHQ-28 with the CBT enhanced group also showing 
significant improvement on the HADS [38]. The CBT group scored significantly higher than 
controls on the GHQ-28 [36] following intervention suggesting that CBT provided benefits 
for the well being of participants that conventional voice therapy alone did not. These 
results however should be interpreted with caution. Multiple t-tests were performed on 
the data with no correction made for multiple comparisons thus increasing the likelihood of 
Type 1 error (finding a significant difference where none exists).  
 This study received a CTAM rating of 48 out of 100 indicating reasonable 
methodological quality. Effect sizes were large for all voice quality outcome measures and 
medium effect sizes were found for depression and anxiety.  
 
Functional Dizziness 
Functional dizziness refers to cases where dizziness has no physical cause or where there is 
a physical cause for dizziness but this is maintained or exacerbated by anxiety. Research has 
found links between dizziness and anxiety disorders in many individuals [10, 62]. Traditional 
treatment for dizziness has traditionally consisted of vestibular rehabilitation (VR) which 
utilises a range of exercises to promote central nervous system compensation for vestibular 
deficits. This treatment however may be of limited use for patients whose dizziness is 
primarily attributable to anxiety. A number of studies have investigated a combination of 
VR and CBT for treating these patients. Johanson and colleagues [63] conducted a 
randomised study of vestibular rehabilitation combined with elements of CBT compared to 
a wait-list control group in an older adult population. Numbers were small but significant 
improvements were noted on the DHI [29]. No changes were found on symptoms of vertigo 
or symptoms of anxiety and depression. Andersson and colleagues [64] conducted a similar 
study again investigating the benefit of vestibular rehabilitation combined with elements of 
CBT to a waitlist control group for a younger adult population. Again improvements were 
seen on the DHI [29] and the intervention was also found to reduce distress compared with 
controls. These studies provide some indication that CBT may be a useful intervention for 
this disorder however CBT was not the main intervention of these studies and its relative 
contribution could not be identified; therefore these studies were not included in this 
review.  
 One study on CBT for functional dizziness and one additional paper that provided 
follow-up data for this study met inclusion and exclusion criteria and were included in this 
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review. Edelman and colleagues randomised forty-one patients with functional dizziness to 
intervention (three sessions of CBT based on the model of panic disorder delivered by a 
clinical psychologist) or a waitlist control group [19]. Significant differences were found for 
both groups between pre-treatment and post-treatment on the DHI [29] and two author 
created, non-validated measures assessing severity of dizziness symptoms and frequency of 
safety behaviours, with the intervention group showing greater improvement than controls 
on all measures. Effect sizes comparing pre-treatment to post-treatment scores on 
dizziness measures were large. They also reported significant differences between the post-
waitlist and post-treatment scores for the two groups on these three measures. No 
significant differences were found in levels of depression, anxiety and stress as measured 
by the DASS-21 [27] when comparing pre and post-treatment scores or post-waitlist and 
post-treatment scores. The intervention was brief providing only three sessions of CBT 
which is less than would generally be required to see a benefit when treating other 
disorders such as depression, anxiety, panic etc. It is possible that this may have accounted 
for the lack of significant improvement on DASS-21 scores.  
 The study received a CTAM rating of 58 out of 100, indicating reasonable 
methodological rigour. There were however a number of limitations; assessments were not 
carried out by independent assessors blinded to treatment condition; therefore this may 
have biased the results. The study had a relatively small sample size (treatment n = 20, 
control n = 21) which also may have impacted the ability to detect meaningful change on 
measures of anxiety and depression following intervention. The use of a waitlist control 
group rather than a no treatment or treatment as usual control group may have been 
problematic in this study. It is possible that the use of wait list control group could 
introduce bias as the anticipation of intervention could itself lead to improvement. 
Participants in the waitlist control group in this study appear to have made improvements 
on dizziness and mood measures without having been administered the intervention 
making it difficult to detect change due to the intervention. A no treatment or treatment as 
usual control group may therefore have strengthened the design of the study. The authors 
subsequently published a follow up paper reporting outcomes at one and six month follow-
up for the intervention group [20]. Results suggested that gains were maintained at both 
follow up periods again with large effect sizes found for improvements on dizziness 
measures.   
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Other FNS 
It is possible that CBT may be efficacious in the treatment of other functional neurological 
disorders such as functional movement disorder or functional paralysis; however our 
search revealed no studies of sufficient quality to allow inclusion in this review.  
 
Discussion 
Functional neurological symptoms are a prevalent problem causing widespread disability 
with significant costs to the individuals and wider society. While a recent review by Hopp 
and LaFrance [14] made a valuable contribution to the area by describing the different 
types of FNSs and summarising the literature in this area, there was no formal assessment 
of the methodological quality of the included studies. The current study attempts to build 
on this by utilising a methodological quality assessment measure to provide information on 
the strength of the evidence for CBT as a treatment for these disorders. The present study 
further builds on the review of Hopp and LaFrance [14] by including additional studies that 
have been published since this article relating to functional voice disorders [19, 20] and 
functional dizziness [18]. 
 Five studies investigating CBT for NES were reviewed [15-17, 21, 22]. One study with 
adequate methodological quality found significant benefits of CBT for seizure reduction 
with a medium to large effect post treatment and a medium effect at six month follow up. 
The other four studies that were included for this condition were all rated as having 
inadequate methodological rigour and all had small sample sizes. Three of these studies 
found a significant reduction in seizure frequency post-treatment, of these two reported 
large effect sizes and one reported a medium to large effect size [15, 22, 17]. One study of a 
group intervention did not find any significant benefit of CBT for reducing seizure frequency 
[16]. In summary there is some evidence that CBT may be an effective intervention for 
reducing seizure frequency in NES, however these results should be replicated in studies 
with higher methodological rigour. There is currently no evidence for the effectiveness of 
CBT group interventions for NES. 
  Two papers on functional dizziness relating to different follow-up periods of the 
same study were reviewed [19, 20]. The study was an RCT of reasonable methodological 
quality that found a significant reduction in dizziness at post-treatment and six month 
follow-up with large effect sizes. This suggests that even brief CBT may be a useful 
intervention for functional dizziness. Further high quality randomised studies utilising 
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validated outcome measures and assessor blinding may be warranted to further investigate 
the potential benefits of CBT for this population.  
Lastly the included paper relating to CBT for functional voice disorder found Voice 
Therapy and CBT-enhanced Voice Therapy had equivalent benefits in relation to 
improvements on voice scales [18]. The CBT-enhanced group also made significant benefits 
on a measure of general health. This study however suffered from some methodological 
limitations. It is as yet unclear what additional benefits CBT may confer above traditional 
voice therapy for this population and further studies of high methodological quality are 
needed.  
Similar to the findings of Hopp and LaFrance [14], the results of this review suggest 
that there is as yet limited evidence to suggest that CBT is an effective intervention for FNS. 
The current review built on the findings of Hopp and LaFrance [14] by assessing the quality 
of the literature in this area. Findings suggest that there were a number of key 
methodological limitations of the studies included in this review. Very few studies 
employed independent assessors blinded to treatment group allocation for evaluating 
outcomes. While most studies employed a treatment manual/protocol, few assessed 
adherence to the protocol or treatment quality. The majority of studies included in this 
review were pre-post studies with only two studies utilising a Randomised Controlled Trial 
(RCT) design and many studies had small sample sizes. Only one study included in the 
review [17] met the CTAM cut-off suggested by Wykes and colleagues [2] for adequate 
methodological quality. This suggests that improvements are needed in the quality of 
research in the area.  
While RCTs may be seen as the gold standard evaluation studies, these may not be 
the most practical for this population. RCTs are time-consuming and the costs of 
conducting them are high, they can be narrow in scope and lack generalisability to 
problems encountered in everyday clinical practice and require large sample sizes for 
randomisation and adequate power which may not be practically achievable. Furthermore 
RCTs require patients to be randomised to either a control or intervention condition, in 
some cases it may be ethically inappropriate to withhold treatment, therefore quasi-
experimental designs where participants act as their own controls may be more suitable. 
Given the paucity of research in this area reflecting the difficulties of conducting RCTs with 
this population, it may be necessary to consider other types of methodology for conducting 
research in this area.   
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 Barnett and colleagues [65] have suggested that Single Case Experimental Designs 
(SCEDs) may be better suited to studies where the aim is to understand and change patient 
functioning and targeted sample sizes are less than 30. At this preliminary stage in 
investigating the potential of CBT for these disorders, SCEDs may be useful for investigating 
the amount, intensity and type of intervention needed to improve patient outcomes. 
Guidelines for evaluating the methodological quality of these studies and 
recommendations on how data can be analysed are available [66-68]. As such SCEDs may 
present a viable alternative to RCTs for investigations of the efficacy and effectiveness of 
CBT for FNS. 
 While the research considered in this review provides some preliminary evidence 
for the benefit of CBT interventions for FNS, further attention needs to be given to what 
elements of CBT may be effective for this population, whether standard CBT needs to be 
tailored to the needs of this population and how many sessions may be needed in order for 
improvements to be achieved.  
 Currently service provision for these individuals is patchy with no defined treatment 
pathways. Service provision, treatment guidelines and pathways and staff training cannot 
be developed for these conditions until we have evidence indicating what treatments are 
effective; therefore studies that are well designed and of high methodological quality are 
urgently needed. 
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Plain English Summary 
Individuals with cognitive impairment arising from acquired brain injury (ABI) are often 
supported to engage in diabetes self-management through the use of verbal guidance 
provided by carers. While this can be effective, it may not always be acceptable to 
individuals who may feel upset and embarrassment as a result of a loss of independence 
and this may in turn lead to emotional strain on carers. Furthermore the costs of providing 
this level of personal support are not insignificant. The use of an automated verbal 
prompting system may hence reduce carer burden and provide a more acceptable 
intervention for individuals.   
Guide was developed by O’Neill and Gillespie (2008) as an assistive technology for 
cognition (ATC) that aims to replicate the verbal guidance often provided to individuals 
with cognitive impairment by carers.  The system prompts users, asks questions of them 
and accepts verbal responses (‘yes’ and ‘no’). Guide has previously been shown to be 
effective in supporting individuals with cognitive impairment to put on their prosthetic 
limbs (O’Neill, Moran & Gillespie, 2010) and to complete their morning routine involving 
getting out of bed and completing personal care (O’Neill, Best, Gillespie & O’Neill, 2013).  
 The aim of this study is to investigate whether Guide can assist individuals with 
cognitive impairment to self-manage their diabetes. Two participants undergoing 
rehabilitation in a specialist brain injury rehabilitation unit with a diagnosis of diabetes and 
ABI took part in the study. These participants were not able to manage their diabetes 
independently because of their ABI. Participants completed a number of baseline sessions 
where they were prompted through the task by staff. They then completed a number of 
sessions where prompting was provided by Guide after which they completed further 
sessions where staff provided prompts. All sessions were video recorded to allow them to 
be scored. 
 Results of the study showed that participants benefited from using the Guide. When 
using Guide they needed less prompting from staff. Participant 1 made fewer errors and 
participant 2 was able to complete more of the steps of the task without any help when 
compared to the baseline phase where staff provided prompts. 
 The practical applications of Guide are potentially wide. It is possible that Guide 
could be used to support people with cognitive impairment due to other causes, for 
example dementia or learning difficulties. It could also be used to support other complex 
behaviours that are usually verbally prompted by carers.  
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Supporting Diabetes Self-Management in Persons with Cognitive Impairment after 
Acquired Brain Injury 
 
 Background. Individuals with cognitive impairment arising from acquired brain 
 injury (ABI) are often supported to engage in diabetes self-management through 
 verbal guidance provided by carers. Guide, developed by O’Neill and Gillespie 
 (2008), is an automated verbal prompting system which aims to replicate the verbal 
 guidance often provided to individuals with cognitive impairment by carers.  
 Aims. The aim of this study is to investigate whether Guide can improve the ability 
 of individuals with cognitive impairment to self-manage their diabetes.  
 Methods. Participants were two individuals recruited from a specialist brain injury 
 rehabilitation unit who had a diagnosis of diabetes and ABI. The study employed an 
 ABA design using multiple baseline across participants Single Case Experimental 
 Design (SCED)  methodology.  
 Results. Results indicated that the use of Guide significantly reduced the level of 
 staff prompting needed for task completion when compared to baseline for both 
 participants. For participant 1, use of Guide reduced the number of errors 
 made during task performance and for participant 2 it increased the proportion of 
 the task that was sequenced correctly.  
 Applications. It is possible that Guide could be used more widely to support 
 individuals with cognitive impairment (e.g. dementia, learning disability) and to 
 support other complex behavioural sequences.  
 
  
 Keywords: acquired brain injury, assistive technology for cognition, executive 
 function, rehabilitation 
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Introduction 
Many chronic medical conditions exist that require individuals to engage in medical self-
management in order to regulate them. Diabetes mellitus is one such condition which 
requires sufferers to self monitor their blood glucose levels and use this information to 
guide their behaviour with regard to food and liquid intake, exercise and insulin 
administration. The cognitive burden of engaging in blood glucose monitoring and planning 
future action can therefore be high, requiring the individual to engage in complex 
sequencing behaviours.  
 Diabetes mellitus is often co-morbid with other conditions which can impair 
cognition including vascular related cognitive impairment, mild cognitive impairment, 
traumatic brain injury and hypoglycaemic brain injury (Biessels, Staekenborg, Brunner, 
Brayne, & Scheltens, 2006; Draelos, Jacobson, Weinger, Widom, Ryan, Finkelstein & 
Simonson, 1995; Luchsinger, Reitz, Patel, Tang, Manly & Mayeux, 2007). Individuals with 
these conditions often require a high degree of personal support in order to engage in 
diabetes self-management and the costs of providing this level of support are not 
insignificant. 
Individuals with cognitive impairment arising from acquired brain injury (ABI) are 
often supported to engage in diabetes self-management through the use of scaffolding 
which refers to a process of providing verbal guidance during task performance (Sawyer, 
2006). Scaffolding has been shown to be effective in reducing errors when learning a new 
skill when compared to supervised trial and error learning in a sample of individuals with 
cognitive impairment (Donaghey, McMillan & O’Neill, 2010). Although carer scaffolding can 
be effective, it may not always be an acceptable intervention to individuals with cognitive 
impairment who may feel upset and embarrassment as a result of a loss of independence 
which may in turn lead to emotional strain on carers. The use of an automated verbal 
scaffolding system may hence reduce carer burden and provide a more acceptable 
intervention for individuals.   
Guide (General User Interface for Disorders of Execution) is an automated verbal 
prompting system that was developed by O’Neill and Gillespie (2008) as an assistive 
technology for cognition (ATC) and which aims to imitate the verbal guidance often 
provided to individuals with cognitive impairment by carers.  The system prompts users, 
asks questions of users and accepts verbal responses (‘yes’ and ‘no’). The system sequences 
complex tasks for users into steps and sub steps and asks a series of questions for each. In 
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this manner a user can be guided through a complex behavioural sequence in a manner 
which simulates carer scaffolding of task performance.  
Errorless learning has been defined as ‘a learning condition that involves the 
minimisation of errors during the learning process’ (Clare & Jones, 2008; p. 1). The concept 
was first applied to individuals with memory impairment arising from acquired brain injury 
by Baddeley & Wilson (1994). They suggested that for people with memory impairment it 
may be important to restrict errors that occur during the learning process as priming and 
implicit memory may mean that once a mistake has been made, individuals with cognitive 
impairment may be more likely to make the same mistake again. They suggested that 
errorless learning may facilitate performance to a greater degree than trial and error 
methods in populations suffering cognitive impairment. Errorless learning principles have 
previously been applied in rehabilitation to practical tasks with success (Baddeley & Wilson, 
1994; Clare et al., 2001). Guide can be conceptualised as an errorless learning approach as 
it prompts users before each action step thus minimising errors.   
Guide has previously been shown to be effective in supporting individuals with 
cognitive impairment to don their prosthetic limbs (O’Neill, Moran & Gillespie, 2010). Use 
of Guide led to a reduction in safety critical errors and omitted steps when compared to 
baseline. It has also been found to be efficacious in supporting an individual to engage in 
their morning routine both in inpatient rehabilitation and home settings, involving getting 
out of bed and engaging in personal care (O’Neill, Best, Gillespie & O’Neill, 2013). Results 
showed that Guide significantly reduced the level of carer prompting required and the 
number of errors made in both an in-patient setting and in the participants own home. 
The current study aims to investigate whether Guide can be used to support 
individuals with diabetes and co-morbid acquired brain injury to engage in the complex self 
care sequence of diabetes self-management, where they are otherwise incapable of doing 
so independently due to cognitive impairment. 
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Aims and Hypotheses 
Aims 
To investigate whether an auditory verbal prompting system (Guide) can increase 
independence in diabetes self-management in individuals with diabetes and co-morbid 
cognitive impairment. 
Hypothesis 
Use of Guide will result in increased independence with participants requiring less 
prompting from carers to complete diabetes self-management when compared to baseline. 
 
Methodology 
Design 
The study employed Single Case Experimental Design (SCED) methodology with a multiple 
baseline across subjects ABA design. In a multiple baseline across subjects design a single 
transition from baseline to treatment phase (AB) is instigated at a different time in each 
subject according to a planned staggered sequence rather than introducing the 
intervention to all participants at the same time. The staggered initiation of the 
intervention makes it implausible that behaviour change has been caused by some 
extraneous variable if change is seen contiguous with treatment phase onset. Barlow and 
colleagues (2009) identified that this type of design has high internal validity and allows for 
greater experimental control as behaviour changes for each subject only after the 
intervention has been implemented. The start date of the intervention phase for 
participants in the study was selected randomly. 
Barnett and colleagues (2012) advocated that SCEDs are better suited than RCTs for 
studies in which changing patient behaviour and functional status are the primary goals and 
targeted sample sizes are less than 10. For these reasons the SCED was selected as the 
most appropriate for the current study.  
An ABA format was employed with baseline, intervention and return to baseline 
phases. The length of the initial baseline phase for each participant was between five and 
ten trials. The actual length of the baseline phase for each participant was selected at 
random by an individual not affiliated with the study prior to the initiation of the study. The 
intervention phase was commenced with participant 1 following 5 baseline trials and with 
participant 2 following nine baseline trials. There were six intervention trials and six return 
to baseline trials for each participant. 
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Ethical Approval  
Ethical approval was sought from and granted by the Scotland A Research Ethics 
Committee [see Appendix 2.2]. Sponsorship for the research was provided by the Brain 
Injury Rehabilitation Trust [see Appendix 2.3]. 
 
Recruitment 
Inclusion  
 Individuals with cognitive impairment and diabetes. 
 Individuals identified as having difficulty independently carrying out diabetes 
management  
 English speaking (prompts provided in English). 
 
Exclusion 
 A level of cognitive impairment that would prevent individuals from being able to 
follow and implement verbal prompts.  
 
Participants 
Participants were recruited from a specialist neurobehavioural assessment and post-acute 
rehabilitation hospital for people with complex needs as a result of a non-progressive 
acquired brain injury. Consent was sought both from participants and their legal guardians 
following provision of information on the study [See Appendix 2.4]. 
 
Participant 1 
Participant 1 was a 40 year old single male. He suffered a severe acquired brain injury 
following a period of hypoglycaemia complicated by intravenous drug use and suspected 
encephalitis in his mid 30’s. Brain imaging showed low attenuation from the right internal 
capsule to the superior right temporal lobe. He was initially admitted to an acquired brain 
injury unit for individuals with challenging behaviour and following a reduction in the 
frequency of aggression was admitted to a neurorehabilitation centre for further 
rehabilitation. At time of recruitment into the study, he had been resident at the unit for a 
period of 15 months and was considered to have severe cognitive impairment.  
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 He had a difficult upbringing, both parents were heavy alcohol users and he was 
brought up in care. There was an indication of possible conduct disorder in childhood with 
a history of antisocial behaviour prior to injury. He attended primary school and some 
secondary school but left without completing any exams. He worked for a short period as a 
butcher’s assistant. He was diagnosed with Type 1 Diabetes in childhood and prior to injury 
had been capable of monitoring his own blood glucose levels. However due to alcohol and 
intravenous drug misuse he was not engaging in this behaviour. Prior to enrolment in the 
study he completed some elements of monitoring independently albeit with frequent 
errors and a high level of supervision from nursing staff. 
 
Participant 2 
Participant 2 was a 59 year old male. He attended secondary school until the age of 16 
years and left without achieving any qualifications. After leaving school, he had a long 
history of unemployment and a history of alcohol dependence and intravenous drug 
misuse. In his mid 50’s he experienced a basal skull fracture and small frontal lobe 
contusion with  evidence on brain imaging of small vessel cerebrovascular disease. At this 
time he was admitted to a neurorehabilitation centre for a period of assessment and 
rehabilitation following which he was discharged home. Approximately two years 
subsequent to this he experienced an ischaemic cerebrovascular accident in the territory of 
the left middle cerebral artery followed a month later by a fall with further injury through 
intracerebral bleeding. This resulted in a further admission for neurorehabilitation and at 
time of recruitment into the study he had been resident in the unit for a period of 21 
months. He experienced marked expressive and receptive dysphasia and moderate ataxia. 
Comprehensive neuropsychological assessment of cognition was not possible due to the 
level of dysphasia, however impairments were categorised as severe and it was 
recommended that he would need full time 24 hour care on discharge from the unit. During 
his first admission to the neurorehabilitation unit, his premorbid functioning was estimated 
to be in the average range using the Wechsler Test of Adult reading (WTAR; Holdnack, 
2001). He was diagnosed with Type II Diabetes in adulthood and this was regulated through 
the use of insulin. His blood glucose levels were monitored at least twice per day by nursing 
staff and more frequently as necessary. At time of recruitment he was completely 
dependent on nursing staff for blood glucose monitoring. 
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Procedure 
In order to develop the protocol of steps and prompts needed to successfully complete the 
task of checking blood sugar levels, the input of a Diabetes Specialist Nurse (DSN) was 
sought [informed consent was obtained see Appendix 2.5]. The DSN was interviewed and 
observed teaching a volunteer, with no prior experience, the task of diabetes self-
management. The dialogue of this interaction was analysed in order to identify the steps 
and sub-steps involved, the prompts given, the questions used to effect accurate sequence 
performance and possible errors.   
This information was then used to map the problem space of the task using Guide. A 
series of prompts (not requiring a response from the user), and checks (in the form of 
questions to the user requiring a ‘yes’ or ‘no’ response) relating to main steps, sub-steps 
and anticipated errors were entered into the system to elicit the desired sequence of 
behaviours in order to lead to successful task performance (See Appendices 2.6 & 2.7). The 
protocol was edited based on the individual needs and capabilities of the participant. The 
protocol used for participant 2 was broadly similar to that used for participant 1; however 
prompts and questions were shortened where possible in order to facilitate understanding. 
 Prior to enrolment in the study, participant 1 was capable of completing some steps 
of the sequence with assistance and prompting from nursing staff. Nursing staff performed 
blood sugar checks for participant 2 who did not complete or attempt to complete any part 
of the sequence himself. No prior training in the use of Guide was needed aside from users 
being instructed to answer only ‘yes’ or ‘no’. During baseline participants were verbally 
prompted through the task by the first author (JM). Prompts were provided based on a 
schedule developed prior to the commencement of the study designed to provide the 
minimal amount of prompting needed to elicit task performance (see Appendix 2.8). Staff 
adherence to the protocol was not formally assessed. In the intervention phase Guide 
provided prompts to the user and asked questions of them, further verbal prompts were 
provided by staff only as necessary (i.e. if the participant made an error or attempted to 
complete steps in the wrong order). In the return to baseline phase, participants were 
again provided with verbal prompts by staff according to the prompting schedule in order 
to enable them to engage in diabetes management. All trials were conducted under the 
supervision of nursing staff in order to ensure participant safety. Data in all phases was 
recorded through video recording. 
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Outcome Measurement 
Outcome of the intervention will be determined through the use of a measure developed 
specifically for the study which is similar to those used by previous studies of Guide (O’Neill 
et al., 2013; See Appendix 2.9). Scores are given over three areas: level of prompting 
needed, number of sequence steps correctly completed and number of errors made. 
Prompting scores require giving a prompt rating for each step of the sequence e.g. picking 
up the test strip tub, opening the tub, taking out one strip etc. A score of 0 points 
represented independent completion of the step with no prompting. One point was given 
for step completion after one verbal prompt, two points after two verbal prompts and 
three points if physical prompting was needed (i.e. pointing to relevant items). The 
maximum prompt score for each step was 4 points if the participant was unable to 
complete the step or required physical assistance. The minimum prompt score for each trial 
was 0 and the maximum score for each trial was 80. The maximum sequence score was 
twelve. One sequence point was awarded for each step completed in the correct sequence 
without the aid of verbal prompting. Lastly participants were given one error point for each 
error they made out of a list of ten possible errors e.g. putting the wrong end of the strip in 
the meter. All trials were scored by the main investigator. Scoring was conducted by 
reviewing video footage of each trial. A random selection of trials (20%) were assessed by a 
second rater to investigate inter rater reliability which proved to be high with agreement of 
91%. Due to the nature of the intervention, it was not possible to for raters to be blinded to 
intervention phase. 
 
Materials 
Equipment utilised included the following: 
1. Johnson & Johnson Accu-Check Aviva blood glucose monitoring device. 
2. Hardware – A PC with Windows XP in order to access the Guide protocol editor. A 
tablet (the Nexus 10 was used but Guide is compatible with a range of tablet 
devices) to run the Guide app. 
3. Protocol –consisting of a sequence of steps and checks which can enable users to 
successfully complete diabetes self-management.  
4. Guide app – Guide is a specially designed app which can receive input from the user 
through the voice recognition capabilities of tablet devices and use this to trigger a 
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response to user in the form of prompts or questions based on an inputted 
protocol. 
5. Video camera for recording of trials. 
 
 Data Analysis 
There are numerous statistical techniques that have been identified as suitable for use in 
studies employing SCEDs. But to date no single best method has been identified for the 
analysis of such data (Parker & Vannest, 2009; Parker, Vannest & Davis, 2011; Ma, 2006; 
Solanas, Manolov & Onghena, 2010). Manolov and colleagues (2011) attempted to bring 
some clarity to this by comparing the effectiveness of four of these methods for estimating 
intervention effect. The authors concluded that data characteristics are vital for choosing 
an appropriate analysis procedure and therefore recommended visual inspection of data in 
order to inform selection of an appropriate analysis procedure. Barnett and colleagues 
(2012) also recommended employing visual analysis of graphed data along with statistical 
analysis in order to draw informed conclusions about intervention effectiveness when using 
SCED methodology. Following the analysis selection procedures outlined by Manolov and 
colleagues (2011) and visual inspection of the data for participants 1 and 2, the Nonoverlap 
of All Pairs (NAP; Parker & Vannest, 2009) method was selected as the most appropriate 
procedure.  
 Analysis was completed using the web based calculator for SCR research developed 
by Vannest and colleagues (Version 1; Vannest, Parker & Gonen, 2011). NAP represents the 
novel application of an established effect size known in other contexts as Area Under the 
Curve, Mann Whitney’s U and the Dominance Statistic amongst others.  The technique has 
been shown to be superior to other nonoverlap techniques in its precision and 
discrimination and in its relationship to other established effect size measures such as 
Pearson’s R² (Parker & Vannest, 2009). It is based on the premise that the amount of 
change in performance due to the introduction of an intervention can be characterised by 
the extent to which data in the baseline and intervention phases do not overlap. According 
to Parker and Vannest (2009) a NAP statistic of 0 – 0.65 represents a weak effect, 0.66 – 
0.92 represents a medium effect and a strong effect is characterised by a test statistic of 
between 0.93 and 1.0. 
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Results 
Participant 1 
The NAP technique makes the assumption that there is no underlying trend in the baseline 
data. The Mann-Kendall test of trend along with visual inspection of the data was employed 
to investigate this. This test statistic was non-significant (p > 0.05; 2-tailed) for the 
prompting, sequence and error data for participant 1, indicating that there was no trend 
present in the baseline data. The level of prompting needed for completion of blood 
glucose monitoring was significantly reduced for participant 1 following the introduction of 
Guide in the intervention phase compared with baseline performance, NAP = 0.97,  p < .05, 
representing a strong effect (See Figure 1). Performance in the intervention phase 
represented near complete independence from prompts provided by staff.  
 
 
Figure 1. Prompting score at each phase for participant 1.  
 
 Sequence scores for participant 1 remained relatively stable across phases and no 
significant difference was found between the baseline and intervention phase, NAP = 0.80, 
p > .05 (see Figure 2). 
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Figure 2. Sequence score at each phase for participant 1.  
 
There was no significant difference between baseline and intervention phases in error 
scores for participant 1, NAP = 0.75, p > .05 (see Figure 3).  Common errors made in the 
baseline phase were using the same finger for the test rather than alternating fingers as 
would be good practice, pricking the finger on the tip rather than the side (pricking the 
finger on the tip can cause a loss of sensation in fingertips over time, therefore pricking the 
side of the finger is considered preferable) and licking blood from the finger rather than 
using a tissue. During the intervention phase participant 1 was consistently pricking the side 
of his finger rather than the tip, however the other errors persisted.  
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Figure 3. Number of errors made by participant 1 according to phase.  
 
Participant 2 
The Mann-Kendall test of trend was employed along with visual inspection of the data to 
investigate whether the assumption of no underlying trend in the baseline data was met. 
This test statistic was non-significant (p > 0.05; 2-tailed) for the prompting, sequence and 
error data, indicating that there was no trend present in the baseline data for participant 2. 
The level of staff prompting needed for completion of blood glucose monitoring was 
significantly reduced for participant 2 following the introduction of Guide in the 
intervention phase compared with baseline performance, NAP = 0.95, p < .01, representing 
a strong effect (see Figure 4). Prompting scores in the return to baseline phase continued to 
be significantly lower than the baseline phase, NAP = 0.90, p < .05, indicating that some 
gains were retained post intervention. 
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Figure 4. Prompting score at each phase for participant 2.  
 
 There was a significant improvement in sequence scores from baseline to 
intervention with analysis revealing a strong effect, NAP = 1.0, p < .01 (see Figure 5). 
Sequence scores in the return to baseline phase continued to be significantly higher than 
the baseline phase, NAP = 0.94, p < .01, indicating that gains were retained post 
intervention.  
 
Figure 5. Sequence scores for participant 2 according to phase. 
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Error scores did not show any significant improvement for participant 2, NAP = 0.42, p > 
.05; however error rates were low in baseline and intervention phases due to the 
participant being dependent on staff for completion of a number of steps (see Figure 6). 
 
Figure 6. Number of errors made in each phase for participant 2. 
 
Discussion 
The use of Guide prompting technology significantly reduced the amount of staff 
prompting needed by participants to accurately perform blood glucose monitoring. This 
suggests that Guide may be useful in the augmentation of carer prompting and may reduce 
the level of support and supervision required. Guide models the cognitive scaffolding 
provided by carers during complex tasks and similar to carer support it can be tailored to 
the individuals needs. With the aid of Guide, participant 1 could complete the main steps of 
the task safely in the absence of staff prompting and supervision.  
Despite significant cognitive impairment, participant 2 made substantial gains, 
progressing from being unable to complete any of the sequence without heavy staff 
prompting to being able to complete roughly 50% of the steps independently in the 
intervention phase. Independent sequence performance levelled out at 50% of steps as the 
participant was unable to complete a number of steps due to manual dexterity difficulties. 
He struggled to hold the lancet correctly and use this to prick his finger; therefore these 
steps had to be carried out by staff.  With appropriate equipment such as pressure 
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activated lancets, it is likely that with the assistance of Guide, participant 2 would have 
been able to achieve a higher level of performance independent of staff prompting as he 
demonstrated an ability to correctly sequence the steps of the task that he was physically 
able to complete. If the use of Guide can eliminate or reduce the need for carer support or 
supervision for tasks this could lead to cost savings in rehabilitation settings.  
 Guide has previously been shown to be effective in supporting procedural tasks and 
tasks with procedural and motivational elements (O’Neill et al., 2010; O’Neill et al., 2013). 
The current study demonstrates its effectiveness in supporting individuals to engage in 
complex self-care tasks. The participants in this study had a severe level of cognitive 
impairment, however still made significant gains with the aid of Guide technology. This 
suggests that individuals with a range of cognitive abilities could stand to benefit and that it 
could perhaps be employed more widely to support individuals with cognitive impairment 
due to other causes (e.g. dementia, learning difficulties). Guide is based on errorless 
learning principles and utilises an auditory verbal interface which is simple and intuitive to 
use and requires no training of the participant. For this reason Guide may be particularly 
useful in enabling individuals with severe cognitive impairment to engage in complex 
procedural tasks with a level of independence as it makes few cognitive demands of them. 
Guide could also be used to support individuals with cognitive impairment with other 
complex behavioural sequences that are generally verbally augmented by carers. 
 There are a significant proportion of individuals living in the community who require 
daily nursing input in the home to perform diabetes management as they are unable to 
correctly sequence the behaviour themselves. While participants in this study were both 
resident in an inpatient rehabilitation unit, Guide has previously been shown to be effective 
in the home environment in assisting individuals with cognitive impairment to engage in 
their morning routine (O’Neill et al., 2013). While examining the effectiveness of the Guide 
diabetes self-management protocol with community dwelling patients was beyond the 
scope of this study, it would be interesting to evaluate this in future studies.  
 The participant’s reactions to the technology appeared to be positive. Prior to the 
onset of the study participant 1 in particular appeared to find the process of being 
prompted by staff irritating and would frequently display verbal aggression toward nursing 
staff if they attempted to correct his performance. Interestingly he did not show similar 
negative reactions to being prompted by Guide. Participant 2 also appeared to enjoy and 
take pride in being able to engage in some steps independently with the use of Guide.  It is 
48 
 
possible that utilising assistive technology such as Guide may lead to decreased levels of 
irritation and increased self-esteem and empowerment in some users when compared with 
carer prompting. Individual preference for carer prompting versus more independent 
performance with the aid of assistive technology may depend on factors such as personality 
and self-esteem and these factors may merit investigation in future studies using Guide.  
 By the end of the study participant 1 was able to complete the essential steps of the 
sequence independently with the use of Guide and participant 2 was able to complete 50% 
of the steps independently. This served the purpose of freeing nursing staff in the 
rehabilitation unit up to attend to other tasks during this time and also appeared to serve 
the function of reducing the level of aggression directed at staff. In this way the use of 
Guide and other assistive technology may reduce the physical and emotional burden on 
carers. This may also merit investigation in future studies. 
 A limitation of Guide in terms of SCED methodology is that the nature of the 
technology means that blinded assessment is not possible which may introduce an element 
of bias into the assessment process. However, the videoing of all trials and the use of a 
predefined prompting schedule and outcome measure potentially allows for trials to be 
rated by a number of different raters in order to ensure reliability of the assessment 
process. The scope of the current study covered only the blood glucose monitoring element 
of diabetes self-management and did not extend to insulin administration. This could 
however, easily be added to the protocol of future studies. While the results of this study 
are promising, they are based on data from only two participants. Future evaluations of 
Guide employing larger sample sizes would be useful in order to confirm the findings. A 
larger randomised controlled trial of Guide for supporting activities such as washing laundry 
is currently underway and is due to report later in 2014. 
 
Conclusions 
Guide may increase independence in diabetes self-management in individuals with 
diabetes and co-morbid cognitive impairment when compared to staff prompting. This 
technology may therefore represent an effective and cost efficient means of supporting 
cognitively impaired individuals through this complex behavioural sequence. 
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Abstract 
Introduction: This account focuses on the development of a range of communication skills 
over the course of clinical training. Communication is recognised as a key skill for 
psychologists by both the Health and Care Professions Council (HCPC) in their Standards of 
Proficiency for Practitioner Psychologists (2012) and by the British Psychological Society 
(BPS) in their Generic Professional Practice Guidelines (2008), therefore this was felt to be 
an important area to focus on. 
Reflection: Gibbs (1988) Reflective Cycle and Chris John’s (1995) Model of Structured 
Reflection were employed to structure my reflections and to allow me to analyse the 
feelings, thoughts and emotions that particular events evoked. Areas addressed included 
communicating in multidisciplinary teams and the factors that lead to the successful 
functioning of teams and communication with clients, specifically building a strong 
therapeutic alliance and communicating effectively with clients with cognitive or 
communication impairments. 
Reflective Review: I reflected on my experience of using the Gibbs and John’s Reflective 
models and the elements of these that I found helpful for my reflective practice. I also 
discussed how my experiences of reflection have changed over the course of clinical 
training with this now viewed as a valuable mechanism of development for my future 
professional career. 
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Abstract 
Introduction: This account focuses on my personal experiences of the challenges of 
conducting research. Research skills are recognised as a key competency for psychologists 
by both the Health and Care Professions Council (HCPC) in their Standards of Proficiency for 
Practitioner Psychologists (2012) and by the British Psychological Society (BPS) in their 
Generic Professional Practice Guidelines (2008), therefore I felt this to be an important area 
to focus on. Consideration is also give to the challenges of remaining actively involved in 
research following qualification and how these challenges might be overcome.  
Reflection: Gibbs (1988) Reflective Cycle and Chris John’s (1995) Model of Structured 
Reflection were employed to structure my reflections and to allow me to analyse the 
feelings, thoughts and emotions that particular events evoked. Areas addressed included 
the challenges of conducting research during training, the challenges of remaining involved 
in research post qualification and the impact that these challenges may have for the 
profession of psychology as a whole. 
Reflective Review: I reflected on my experience of using the Gibbs and John’s Reflective 
models and the elements of these that I found helpful for my reflective practice. I also 
discussed how the writing of this account has allowed me to appreciate the value of 
utilising models of reflection to reflect on areas other than clinical practice which is a skill 
that I will carry forward to life as a qualified clinical psychologist. 
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Systematic Review Appendices 
Appendix 1.1 Instructions to authors for submission to Journal of Neurology 
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Appendix 1.2 Clinical trials Assessment measure (Tarrier & Wykes, 2004) 
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Major Research Project Appendices 
Appendix 2.1 Instructions to authors for submission to Neuropsychological Rehabilitation 
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Appendix 2.2 (i) Letter of Favourable Ethical Opinion 
 
 
71 
 
 
 
 
72 
 
 
 
 
 
 
 
73 
 
 
 
 
 
74 
 
 
 
 
 
 
 
75 
 
Appendix 2.2 (ii)  Letter confirming compliance with conditions of ethical approval. 
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Appendix 2.3 Sponsorship Letter 
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Appendix 2.4 (i)   Participant Information Sheet 
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Appendix 2.4 (ii)   Participant Consent Form 
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Appendix 2.4 (iii)  Guardian Information Sheet 
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Appendix 2.4 (iv)  Guardian Consent Form 
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Appendix 2.5 (i)  Professional Information Sheet 
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Appendix 2.5 (ii)  Professional Consent Form 
 
 
86 
 
Appendix 2.6  Guide Protocol Editor – Main Steps 
 
* Image removed due to copyright 
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Appendix 2.7  Guide Protocol Editor – example of prompts for ‘getting ready’ step 
 
* Image removed due to copyright 
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Appendix 2.8  Prompting Schedule 
 
Prompt Schedule – Blood Glucose Monitoring 
The following is a list of prompts that can be provided to participants at each phase if they 
cannot complete a step unaided:  
1. Open the test strip tub 
2. Take out one strip 
3. Close the tub 
4. Put the strip in the meter (gold end first) 
5. Pick up the lancet 
6. Take off the lid 
7. Select a finger to use (try to use a different finger to the one you used last time) 
8. Hold the lancet to the side of your finger 
9. Click the lancet to prick your finger 
10. Put the used lancet in the sharps box 
11. Squeeze your finger to get some blood 
12. Pick up the meter 
13. Hold the end of the test strip to the blood on your finger until it beeps 
14. Remove the strip from the meter 
15. Place the used strip in the sharps box 
16. Tidy up – put all items back in the bag    
 
Allow the participant 5 seconds to start the first step of the task before providing a prompt. 
Increasing prompts may be provided in the order specified below if the participant fails to 
start the step or starts an incorrect step. Wait 5 seconds between providing each level of 
prompt to allow the participant to respond: 
 1st verbal prompt 
 2nd verbal prompt 
 Point to the correct item/task whilst repeating verbal prompt 
 Provide physical assistance e.g. hand them the correct item/assist them with 
completing the step. 
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Appendix 2.9  Blood Glucose Monitoring Outcome Measure 
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Appendix 2.10 Major Research Project Proposal 
Supporting Diabetes Self-management in Persons with Cognitive Impairment after Acquired 
Brain Injury 
 
Background. Individuals with cognitive impairment arising from acquired brain injury (ABI) 
are often supported to engage in diabetes self-management through the use of verbal 
guidance provided by carers. This disablement incurs burden and emotional strain for 
carers, and potential upset and embarrassment for individuals.  
GUIDE, developed by O’Neill and Gillespie (2008) is an automated verbal prompting 
system which aims to replicate the verbal guidance often provided to individuals with 
cognitive impairment by carers. It has previously been shown to be effective in supporting 
individuals with cognitive impairment to don their prosthetic limbs and to engage in their 
morning routine.  
Aims. The aim of this study is to investigate whether the GUIDE system can improve the 
ability of individuals with cognitive impairment to self-manage their diabetes.  
Methods. Participants will be five to ten individuals recruited from two specialist brain 
injury rehabilitation units and a diabetes clinic in Glasgow, who have a diagnosis of diabetes 
and ABI. Informed consent will be sought from all participants capable of providing it; 
otherwise it will be sought from their legal guardian. Participants will complete a brief 
neuropsychological battery to establish a cognitive profile. The study will employ an ABA^ 
design using multiple baseline Single Case Experimental Design (SCED) methodology.  
Applications. It is possible that GUIDE could be used more widely to support individuals 
with cognitive impairment (e.g. dementia) in diabetes self-management and to support 
other complex behavioural sequences.   
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Introduction 
Many chronic medical conditions exist that require individuals to engage in medical self 
management in order to regulate them. Diabetes mellitus is one such condition which 
requires sufferers to self monitor their blood glucose levels and use this information to 
guide their behaviour with regard to food and liquid intake, exercise and insulin 
administration. The cognitive burden of engaging in blood glucose monitoring and planning 
future action can therefore be high requiring the individual to engage in complex 
sequencing behaviours.  
Diabetes mellitus is often co morbid with other conditions which can impair cognition 
including vascular related cognitive impairment, mild cognitive impairment, traumatic brain 
injury and hypoglycaemic brain injury. Individuals with these conditions can often require a 
high degree of personal support in order to engage in diabetes self management and the 
costs of providing this level of support are not insignificant. 
Individuals with cognitive impairment arising from acquired brain injury (ABI) are 
often supported to engage in diabetes self management through the use of scaffolding 
which refers to a process of providing verbal guidance during task performance (Sawyer, 
2006). Scaffolding has been shown to be effective in reducing errors when learning a new 
skill when compared to supervised trial and error learning in a sample of individuals with 
cognitive impairment (Donaghey, McMillan & O’Neill, 2010). Although carer scaffolding can 
be effective, it may not always be an acceptable intervention to individuals with cognitive 
impairment who may feel upset and embarrassment as a result of a loss of independence 
which may in turn lead to emotional strain on carers. The use of an automated verbal 
scaffolding system may hence reduce carer burden and provide a more acceptable 
intervention for individuals.   
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GUIDE (General User Interface for Disorders of Execution) system was developed by 
O’Neill and Gillespie (2008) as an assistive technology for cognition (ATC) which aims to 
imitate the verbal guidance often provided to individuals with cognitive impairment by 
carers.  The system prompts users, asks questions of users and accepts verbal responses 
(‘yes’ and ‘no’). The system sequences complex tasks for users into steps and sub steps and 
asks a series of questions for each. In this manner a user can be guided through a complex 
sequence in a manner which simulates carer scaffolding of task performance.  
Errorless learning has been defined as ‘a learning condition that involves the 
minimisation of errors during the learning process’ (Clare and Jones, 2008; p. 1). The 
concept was first introduced by Baddeley & Wilson (1994). They suggested that for people 
with memory impairment it may be important to restrict errors that occur during the 
learning process as priming and implicit memory may mean that once a mistake has been 
made, individuals with cognitive impairment may be more likely to make the same mistake 
again. They suggested that errorless learning may facilitate performance to a greater 
degree than trial and error methods in populations suffering cognitive impairment. 
Errorless learning principles have previously been applied in rehabilitation to practical tasks 
with success (Baddeley & Wilson, 1994; Clare et al., 2001) GUIDE can be conceptualised as 
an errorless learning approach as it prompts users before each action step thus minimising 
errors.  
GUIDE has previously been shown to be effective in supporting individuals with 
cognitive impairment to don their prosthetic limbs (O’Neill et al. 2010). Use of the GUIDE 
system led to a reduction in safety critical errors and omitted steps when compared to 
baseline. It has also been found to be efficacious in supporting an individual to engage in 
their morning routine involving getting out of bed and engaging in personal care (O’Neill et 
al., 2013). Results showed that the GUIDE system significantly reduced the level of carer 
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prompting required and the number of errors made in both an in-patient setting and in the 
participants own home. 
The current study aims to investigate whether GUIDE can be used to support 
individuals with diabetes mellitus and co-morbid acquired brain injury  to engage in 
diabetes self management, a complex self care sequence where they are otherwise 
incapable of doing so independently due to cognitive impairment. 
 
Aims and Hypotheses 
Aims 
To investigate whether an auditory verbal prompting system (GUIDE) can facilitate diabetes 
self management in individuals with diabetes mellitus and co-morbid cognitive impairment. 
Hypotheses 
Use of the GUIDE system will produce significant performance improvements compared to 
baseline. 
 
Plan of Investigation 
Participants 
Participants will be individuals with a diagnosis of diabetes mellitus and co-morbid 
cognitive impairment, who as a result of their cognitive impairment have difficulty self 
managing their diabetes. It is estimated that between five and ten participants will be 
recruited. Participants will be recruited from Graham Anderson House (GAH; a specialist 
neurobehavioural assessment and post-acute rehabilitation hospital for people with a non-
progressive acquired brain injury) where it is estimated that 10% of annual admissions have 
co-morbid diabetes which they require significant support in managing. Participants will 
also be recruited from the Huntercombe Brain Injury Rehabilitation Centre in Murdostoun.  
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Inclusion and Exclusion Criteria 
Inclusion  
 Participants must have cognitive impairment. 
 Participants should be able to carry out diabetes self management without errors or 
omissions when provided with verbal prompts from nursing staff. 
 Participants must have been identified as having difficulty independently carrying 
out diabetes self management  
 Participants must be English speaking (as prompts will be provided in English). 
Exclusion 
 A level of cognitive impairment that would prevent individuals from being able to 
follow and implement verbal prompts.  
 Individuals who can safely carry out diabetes self management without support. 
 
Recruitment Procedures 
Informed consent will be sought from all participants capable of providing it. Where 
participants lack capacity, consent will be sought from their legal guardian.  
Measures 
The cognitive profile of participants will be established by administering the following brief 
neuropsychological test battery: 
 Galveston Orientation and Amnesia Test (GOAT; Levin, O’Donnell & Grossman, 
1979) – Measures experience of self and time functions. 
 Hospital Anxiety and Depression Scales (HADS; Zigmond & Snaith, 1983) - assesses 
emotional functions. 
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 List Learning and Complex Figure Test from the BIRT Memory And Information 
Processing Battery (BMIPB; Coughlan, Oddy & Crawford, 2007) – as a measure of 
memory. 
 Behavioural Assessment of Dysexecutive Syndrome (BADS; Wilsom, Alderman, 
Burgess, Emslie & Evans, 1996) – as a measure of higher-level cognitive functions. 
 Test of Everyday Attention (TEA; Robertson, Ward, Ridgeway & Nimmo-Smith, 1994) 
– assesses attention functions. 
 Test of Premorbid Functioning - UK Version (TOPF UK; Wechsler, 2011)  
Outcome of the intervention will be determined through the use of two measures. The 
first outcome measure will allow for the recording of the number of sequencing errors 
made by participants in baseline, intervention and return to baseline phases and the 
number of prompts required by nursing or support staff to ensure sequence performance. 
The second measure of outcome will consist of a rating of participant satisfaction with the 
intervention following each trial. 
 
Design 
 A series of between five and ten single-participant investigations will be conducted using 
Single Case Experimental Design (SCED) methodology with a multiple baseline across 
subjects design. The aim of the current study is to produce reliable improvement in 
diabetes self management in individuals with diabetes mellitus and co-morbid cognitive 
impairment. Depending on their level of cognitive impairment some participants may be 
expected to retain gains once the GUIDE system is removed, therefore a ‘return to baseline’ 
phase will also be employed to identify whether participants retain gains after the removal 
of the intervention.  
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In a multiple baseline across subjects design a single transition from baseline to 
treatment (AB) is instigated at a different time to each subject according to a planned 
staggered sequence rather than introducing the intervention to all participants at the same 
time. The staggered initiation of the intervention makes it implausible that behaviour 
change has been caused by some extraneous variable. Barlow and colleagues (2009) 
identified that this type of design has high internal validity and allows for greater 
experimental control as behavior changes for each subject only after the intervention has 
been implemented. 
 
Research Procedures 
Currently individuals at GAH are supported to perform diabetes self-management through 
prompts from nursing staff or rehabilitation support workers. Programming the GUIDE 
system to support individuals through diabetes self management would consist of a 
number of steps. Firstly the problem space would need to be defined. This would involve 
observation of a Diabetes Specialist Nurse supporting an individual with acquired brain 
injury through diabetes self-management. This process would be video recorded and the 
dialogue analysed in order to develop a protocol of the steps involved, the prompts given 
and the questions used to effect accurate sequence performance.  
This protocol will then be used to map the problem space of the task using the 
GUIDE system. A series of prompts relating to one action at a time are entered into the 
system in order to elicit the desired sequence of behaviours which will lead to successful 
task performance. The GUIDE system attempts to simulate the scaffolding support provided 
by carers by modelling prompts on those provided by carers. These prompts will generally 
be in the form of questions to the user and will require a verbal response from them. 
Checks for any anticipated mistakes or deviations from the desired sequence are also 
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programmed into the GUIDE system. Prompts may be tailored to the individual user if 
necessary. 
 During baseline participants will be provided with verbal prompts by nursing staff in 
order to enable them to engage in diabetes management. Prior to the intervention phase, 
participants will be trained briefly in the use of the GUIDE system and voice recognition 
software. During the intervention phase, the GUIDE system will be set to verbally prompt 
participants that it time to engage in diabetes self-management. At these times the GUIDE 
system will prompt the participant through the task; however a nurse will be present in 
order to correct any safety-critical errors or omissions that might occur. In the return to 
baseline phase, participants will again be provided with verbal prompts by nursing staff in 
order to enable them to engage in diabetes management. Data in all phases will be 
recorded through video recording of participants on task behaviour. 
 
 Data Analysis 
There are numerous statistical techniques that have been identified as suitable for use in 
studies employing SCED. But to date no single best method has been identified for the 
analysis of such data (Parker & Vannest, 2009; Parker, Vannest & Davis, 2011; Ma, 2006; 
Solanas, Manolov & Onghena, 2010). Manolov and colleagues (2011) attempted to bring 
some clarity to this by comparing the effectiveness of four of these methods for estimating 
intervention effect. The authors concluded that data characteristics are vital for choosing 
an appropriate analysis procedure and therefore recommended visual inspection of data in 
order to inform selection of an appropriate analysis procedure. Barnett and colleagues 
(2012) also recommended employing visual analysis of graphed data along with statistical 
analysis in order to draw informed conclusions about intervention effectiveness when using 
SCED methodology. An appropriate data analysis procedure will therefore be selected 
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following visual inspection of collected data according to the procedures outlined by 
Manolov and colleagues (2011). Procedures employed may include Improvement rate 
difference (IRD; Parker et al., 2009), nonoverlap of all pairs (NAP; Parker & Vannest, 2009) 
and slope and level change (SLC; Solanas et al., 2010). Manolov and colleagues (2011) that 
IRD may be useful for data with no quadratic or linear trend and no autocorrelation or 
heteroscedasticity. They suggested that NAP (with correction for linear trend) and SLC can 
be used where autocorrelation or heteroscedasticity are present.  
 
Justification of Sample Size 
The randomised controlled trial (RCT) is widely considered to be the gold standard of 
research designs, providing the best evidence of intervention effectiveness (Sackett et al, 
1996). While RCTs can reduce bias in studies through randomisation and blinding, they can 
also be costly and time consuming and due to their rigor may lack generalisability.  In the 
field of rehabilitation, many interventions are by necessity highly individualised, meaning 
that an RCT design may be inappropriate. The protocol of the current study may need to be 
individualised for participants, for example in order to reflect differing levels of cognitive 
ability and where different equipment is being used. RCTs also require large sample sizes in 
order for randomisation procedures to be effective which may not be feasible to achieve in 
rehabilitation research. The target population of the current study is very specific and it 
would likely be impossible to recruit sufficient numbers to utilise an RCT design.  
Single case experimental designs (SCED) have been referred to as being ‘the most 
effective and powerful’ nonrandomised experimental designs (Shadish, Cook, & Campbell, 
2001; p. 171). Barnett and colleagues (2012) advocated that SCED are better suited than 
RCTs for studies in which changing patient behaviour and functional status are the primary 
goals and targeted sample sizes are less than 10. For these reasons the SCED would seem 
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the most appropriate for the current study and a sample size of between five and ten 
individuals would seem a reasonable target for this type of design. 
 
Settings and Equipment 
Participants will be tested in the base of the organisation from which they were recruited. 
Equipment required includes the following: 
6. Johnson & Johnson Accu-Check blood glucose monitoring device 
7. Hardware – A PC with Windows XP to run the GUIDE software program and 
additional hardware to enable audio presentation to the user and verbal responses 
from the user to be received. This will consist of either an array microphone and 
speaker or a wireless headset with earphones and microphone 
8. Voice Recognition Software – this is needed in order for the GUIDE system to 
receive verbal input from the participant. The Dragon Naturally Speaking 9.5 
software will be used. 
9. Protocol – the protocol consists of a sequence of steps and checks which can enable 
users to successfully complete diabetes self management. This will be developed 
through consultation with specialist diabetes nursing staff and through observation 
of individuals being prompted through diabetes self management by nursing staff or 
rehabilitation support workers 
10. GUIDE software program – GUIDE is a specially designed software program which 
can receive input from the voice recognition program and use this to trigger a 
response to user input including the provision of prompts or asking questions of the 
user based on the inputted protocol. 
11. Video camera 
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Health and Safety Issues 
Researcher Safety Issues 
None identified. GUIDE trials will be carried out by nursing staff. 
Participant Safety Issues 
Use of blood glucose monitoring equipment by individuals with cognitive impairment is a 
potential risk. Supervision will be provided by qualified nursing staff at all times during 
intervention in order to prevent safety critical errors and ensure participant safety. 
 Further details of Health and Safety issues can be found in the appendices (see 
Appendix A) 
 
Ethical Issues (including where submissions will be made) 
Memory impairment and executive dysfunction are common in individuals with brain injury 
meaning that they may lack the capacity to consent to participating in research. Due to 
their level of cognitive impairment, these individuals stand to have the most to gain from 
the current intervention, therefore to exclude them due to a lack of capacity may 
disadvantage them compared to those who have capacity. Ethical approval will therefore 
be sought from the Scotland A Research Ethics Committee.  
 
Financial Issues 
 The use of a University of Glasgow encrypted laptop would be required. 
 GUIDE software to be provided free of charge by the field supervisor’s organisation. 
 Dragon Naturally Speaking 9.5 voice activation software will be required. 
Full details of expenses are included in the appendices (see Appendix B). 
 
Timetable 
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It is envisaged that ethical approval will be sought in December 2013 and that recruitment 
and investigation will commence in January 2014 (see Appendix C). 
 
Practical Applications 
The practical applications of GUIDE are potentially wide. It is possible that GUIDE could be 
used more widely to support individuals with cognitive impairment (e.g. dementia) in 
diabetes self-management. GUIDE could also be used to support other complex 
behavioural sequences that are generally verbally augmented by carers.  
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